Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program.-MedSci.cn

Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program.

McCleary, NJ; Harmsen, WS; VanCutsem, E; Sobrero, AF; Goldberg, RM; Tabernero, J; Seymour, M; Saltz, LB; Giantonio, BJ; Dirk, A; Rothenberg, ML; Koopman, M; Schmoll, HJHJ; Pitot, HC; Hoff, PM; Falcone, A; De Gramont, A; Shi, Q; Lichtman, SM

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

科室
- - 订阅+
  - 更多科室
工具
服务